Adage Capital Partners Gp, L.L.C. Aeglea Bio Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.5 - $2.66 $750,000 - $3.99 Million	1,500,000 New	1,500,000 $758,000
Q1 2022 May 16, 2022	SELL	$1.87 - $4.77 $1.87 Million - $4.77 Million	-1,000,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.5 - $8.42 $8.75 Million - $21.1 Million	-2,500,000 Reduced 71.43%	1,000,000 $4.75 Million
Q3 2021 Nov 15, 2021	BUY	$6.03 - $7.95 $2.72 Million - $3.58 Million	450,419 Added 14.77%	3,500,000 $27.8 Million
Q2 2021 Aug 16, 2021	BUY	$6.32 - $8.38 $641,100 - $850,067	101,440 Added 3.44%	3,049,581 $21.2 Million
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $296,486 - $375,871	-43,859 Reduced 1.47%	2,948,141 $23.3 Million
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $651,000 - $933,000	100,000 Added 3.46%	2,992,000 $21.2 Million
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $5.71 Million - $15.7 Million	1,423,409 Added 96.92%	2,892,000 $26.8 Million
Q1 2019 May 15, 2019	BUY	$7.6 - $9.4 $76,000 - $94,000	10,000 Added 0.69%	1,468,591 $11.8 Million
Q4 2018 Feb 14, 2019	BUY	$6.51 - $10.19 $3.53 Million - $5.53 Million	542,889 Added 59.29%	1,458,591 $10.9 Million
Q3 2018 Nov 14, 2018	BUY	$8.24 - $11.0 $206,000 - $275,000	25,000 Added 2.81%	915,702 $8.76 Million
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $5.04 Million - $6.98 Million	640,702 Added 256.28%	890,702 $9.42 Million
Q1 2018 May 15, 2018	BUY	$5.07 - $10.9 $1.27 Million - $2.73 Million	250,000 New	250,000 $2.48 Million

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.